Charles & Colvard, Ltd. (CTHR) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2025Q3
the company's inability to generate positive free cash flow, evidenced by a -37.4% FCF margin in 2025Q3, combined with a dwindling $1.3 million cash balance, presents an unsustainable risk profile for investors.
Charles & Colvard, Ltd. (CTHR) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Key metrics vs top competitors for Charles & Colvard, Ltd. (CTHR)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $0.10 | $304.03K | -0.02 | -26.68% | -65.42% | -43.91% | — | |
| $81.86 | $3.22B | 11.56 | 1.64% | 4.29% | 16.01% | — | |
| $18.04 | $264.08M | 64.43 | — | 0.55% | 1.88% | — | |
| $18.84 | $2.17B | 24.47 | -21.79% | 3.94% | 99.46% | — | |
| $4.15 | $245.27M | -2.86 | -12.28% | -6.18% | -61.58% | — | |
| $1.13 | $178.67M | -4.52 | 3.63% | -2.62% | -13.97% | — |
Charles & Colvard, Ltd. (CTHR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Get notified when CTHR posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Charles & Colvard, Ltd. (CTHR) stock FAQ — growth, dividends, profitability & financials explained
Charles & Colvard, Ltd. (CTHR) reported $15.7M in revenue for fiscal year 2024. This represents a 15648% increase from $0.1M in 1997.
Charles & Colvard, Ltd. (CTHR) saw revenue decline by 26.7% over the past year.
Charles & Colvard, Ltd. (CTHR) reported a net loss of $12.0M for fiscal year 2024.
Charles & Colvard, Ltd. (CTHR) has a return on equity (ROE) of -43.9%. Negative ROE indicates the company is unprofitable.
Charles & Colvard, Ltd. (CTHR) had negative free cash flow of $5.5M in fiscal year 2024, likely due to heavy capital investments.